Residual neuromuscular blockade in myotonic dystrophy: Lessons unlearned and sugammadex

Anaesthesia and Intensive Care

Volumn 39, Issue 4, 2011, Pages 756-757

  Stewart, P A ^a   Phillips, S ^a   De Boer, H D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM; SUGAMMADEX; VECURONIUM; GAMMA CYCLODEXTRIN DERIVATIVE;

COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; MUSCLE SPASM; MYOTONIC DYSTROPHY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; RESIDUAL NEUROMUSCULAR BLOCKADE; UPPER RESPIRATORY TRACT OBSTRUCTION; ADULT; AIRWAY OBSTRUCTION; ANESTHETIC RECOVERY; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; ENDOTRACHEAL INTUBATION; EVIDENCE BASED MEDICINE; FEMALE; MONITORING; NOTE; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY; SYNAPTIC TRANSMISSION;

AIRWAY OBSTRUCTION; ANESTHESIA RECOVERY PERIOD; CHOLINESTERASE INHIBITORS; EVIDENCE-BASED MEDICINE; FEMALE; GAMMA-CYCLODEXTRINS; GUIDELINES AS TOPIC; HUMANS; INTUBATION, INTRATRACHEAL; MONITORING, INTRAOPERATIVE; MONITORING, PHYSIOLOGIC; MUSCARINIC ANTAGONISTS; MYOTONIC DYSTROPHY; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PREGNANCY; SYNAPTIC TRANSMISSION; YOUNG ADULT;

EID: 80051943027     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Owen PM, Chu C. Emergency caesarean section in a patient with myotonic dystrophy: a case of failed postoperative extubation in a patient with mild disease. Anaesth Intensive Care. 2011; 39:293-298.
2. Beemer GH, Rozental P. Postoperative neuromuscular function. Anaest Intensive Care 1986;14:41-45.
3. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010;111:120-128.
4. Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010;111:129-140.
5. Adams DC, Heyer EL. Problems of anesthesia in patients with neuromuscular disease. Anesth Clin North Am 1997;15:673-689.
6. Baumgartner P. Rocuronium and sugammadex in myotonic dystrophy. Anaesth Intensive Care 2010;38:959-960.
7. Matsuki Y HM. The use of sugammadex in a patient with myotonic dystrophy. Eur J Anaesthesiol 2011;28:145-146.